IGF2BP3 and central nervous system cancer: Our data confirmed the up-regulation of ANG (Figure 9A), EXO1 (Figure 9B), FBXO17 (Figure 9C), IGF2BP3 (Figure 9D), and NSUN7 (Figure 9E) in glioma than normal samples (all p < 0.0001).